TACS Consumer Health
A disruptive, consumer healthcare provider of direct subscription access to prescription strength drugs without required MD oversight
- Stage Prototype Ready
- Industry Consumer Products
- Location Livingston, NJ, USA
- Currency USD
- Founded January 2011
Company Summary
NJ early stage company with a $10-25B target annual market. TACS Consumer Healthcare can capture a majority of sales through successive pipeline launches using a patent-pending model enabling Rx to Non-Rx switches of drugs not normally able to be regulated as Over the Counter. Yr 1 National US target of $200MM with sales growing to $825MM by Yr 5 for the first drug only. Cumulative projected 10-year EBITDA of $500MM.
Team
-
Keith S. LernerFounder & CEO
Keith Lerner is a stand-out leader, driver and implementer of business innovation, strategically growing both established and new consumer packaged goods brands to new market share, revenue and profit highs. Keith has played a pivotal leadership role in developing share building brand campaigns, external innovation deals and improved operating processes for numerous iconic consumer brands. He has also led a variety of successful new brand la
Advisors
-
Covington & Burling LLPLawyerUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.